ForteBio (Menlo Park, CA) supplier of label-free technology for the development of life science and pharmaceutical products, closed a $25M Series C financing. Participants include OrbiMed Advisors, MPM Capital, Alloy Ventures, Latterell Venture Partners, The Vertical Group and Versant Ventures.